TY - JOUR
T1 - They Affect the Person, but for Better or Worse? Perceptions of Electroceutical Interventions for Depression Among Psychiatrists, Patients, and the Public
AU - Bluhm, Robyn
AU - Castillo, Emily
AU - Achtyes, Eric D.
AU - McCright, Aaron M.
AU - Cabrera, Laura Y.
N1 - Funding Information:
RB, EC, AM, and LC have declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. EA has received research support from the following entities in the preceding 12 months: Alkerms, Astellas, Biogen, Boehringer-Ingelheim, InnateVR, Janssen, National Network of Depression Centers, Neurocrine Biosciences, Novartis, Otsuka, Pear Therapeutics, Takeda, and the Vanguard Research Group. He has also served on advisory boards or consulted with:Alkermes, F. Hoffman-La Roche, Janssen, Otsuka/Lundbeck, and Sunovion.
Publisher Copyright:
© The Author(s) 2021.
PY - 2021/11
Y1 - 2021/11
N2 - Responding to reports of cases of personality change following deep brain stimulation, neuroethicists have debated the nature and ethical implications of these changes. Recently, this literature has been challenged as being overblown and therefore potentially an impediment to patients accessing needed treatment. We interviewed 16 psychiatrists, 16 patients with depression, and 16 members of the public without depression, all from the Midwestern United States, about their views on how three electroceutical interventions (deep brain stimulation, electroconvulsive therapy, and transcranial magnetic stimulation) used to treat depression might affect the self. Participants were also asked to compare the electroceuticals’ effects on the self with the effects of commonly used depression treatments (psychotherapy and pharmaceuticals). Using qualitative content analysis, we found that participants’ views on electroceuticals’ potential effects on the self mainly focused on treatment effectiveness and side effects. Our results have implications for both theoretical discussions in neuroethics and clinical practice in psychiatry.
AB - Responding to reports of cases of personality change following deep brain stimulation, neuroethicists have debated the nature and ethical implications of these changes. Recently, this literature has been challenged as being overblown and therefore potentially an impediment to patients accessing needed treatment. We interviewed 16 psychiatrists, 16 patients with depression, and 16 members of the public without depression, all from the Midwestern United States, about their views on how three electroceutical interventions (deep brain stimulation, electroconvulsive therapy, and transcranial magnetic stimulation) used to treat depression might affect the self. Participants were also asked to compare the electroceuticals’ effects on the self with the effects of commonly used depression treatments (psychotherapy and pharmaceuticals). Using qualitative content analysis, we found that participants’ views on electroceuticals’ potential effects on the self mainly focused on treatment effectiveness and side effects. Our results have implications for both theoretical discussions in neuroethics and clinical practice in psychiatry.
UR - http://www.scopus.com/inward/record.url?scp=85117519466&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85117519466&partnerID=8YFLogxK
U2 - 10.1177/10497323211037642
DO - 10.1177/10497323211037642
M3 - Article
C2 - 34672815
AN - SCOPUS:85117519466
SN - 1049-7323
VL - 31
SP - 2542
EP - 2553
JO - Qualitative Health Research
JF - Qualitative Health Research
IS - 13
ER -